Phase I Study to Evaluate the Safety, Tolerability and E

Project: Research project

Project Details

Description

Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 in Combination with Tremelimumab or Tremelimumab Alone in Subjects with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
StatusActive
Effective start/end date2/1/1511/30/21

Funding

  • MedImmune, LLC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.